Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 161-167

  Min, Wei Ping ^a   Gorczynski, Reginald ^a   Huang, Xu Yan ^a   Kushida, Michelle ^b   Kim, Peter ^b   Obataki, Masayuki ^b   Lei, Li ^a   Suri, Rakesh M ^a   Cattral, Mark S ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DNA MODIFICATION; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0033970592     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.161     Document Type: Article

References (64)

1. Steinman, R. M. 1991. The dendritic cell system and ils role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
3. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subset differentially regulates the class of immune responses in vivo. Proc. Natl. Acad. Sci. USA 96:1036.
4. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y.-J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
5. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317.
6. Takayama, T., Y. Nishioka, L. Lu, M. T. Lotze, H. Tahara, and A. W. Thomson. 1998. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66:1567.
7. Lee, W. C., C. Zhong, S. Qian, Y. Wan, J. Gauldie, Z. Mi, P. D. Robbins, A. W. Thomson, and L. Lu. 1998. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β. Transplantation 66:1810.
8. Austyn, J. M., J. W. Kupiec-Weglinski, D. F. Hankins, and P. J. Morris. 1988. Migration patterns of dendritic cells in the mouse: homing to T cell-dependent areas of spleen, and binding within marginal zone. J. Exp. Med. 167:646.
9. Austyn, J. M. 1998. Dendritic cells. Curr. Opin. Hematol. 5:3.
10. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
11. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
12. Korbutt, G. S., J. F. Elliott, and R. V. Rajotte. 1997. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46:317.
13. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
14. Suss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789.
15. Lu, L., S. Qian, P. A. Hershberger, W. A. Rudert, D. H. Lynch, and A. W. Thomson. 1997. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158:5676.
16. George, J. F., S. D. Sweeney, J. K. Kirklin, E. M. Simpson, D. R. Goldstein, and J. M. Thomas. 1998. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat. Med. 4:333.
17. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
18. Suri, R. M., and J. M. Austyn. 1998. Bacterial lipopolysaccharide contamination of commercial collagen preparations may mediate dendritic cell maturation in culture. J. Immunol. Methods 214:149.
19. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185.
20. + T cells. Nat. Med. 4:1377.
21. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
22. Zhang, H., X. Su, D. Liu, W. Liu, P. Yang, Z. Wang, C. K. Edwards, H. Bluethmann, J. D. Mountz, and T. Zhou. 1999. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J. Immunol. 162: 1423.
23. Corry, R. J., H. J. Winn, and P. S. Russel. 1973. Primarily vascularized allografts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16:343.
24. Rastellini, C., L. Lu, C. Ricordi, T. E. Starzl, A. S. Rao, and A. W. Thomson. 1995. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60:1366.
25. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62:659.
26. Lu, L., W. Li, F. Fu, F. G. Chambers, S. Qian, J. J. Fung, and A. W. Thomson. 1997. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64:1808.
27. Yamaguchi, Y., H. Tsumura, M. Miwa, and K. Inaba. 1997. Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15:144.
28. Song, W., H. L. Kong, H. Carpenter, H. Torii, R. Granstein, S. Rafti, M. A. Moore, and R. G, Crystal. 1997. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186:1247.
29. Wan, Y., J. Bramson, R. Carter, F. Graham, and J. Gauldie. 1997. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum. Gene Ther. 8:1355.
30. McArthur, J. G., and R. C. Mulligan. 1998. Induction of protective anti-tumor immunity by gene-modified dendritic cells. J. Immunother. 21:41.
31. Ahuja, S. S., S. Mummidi, H. L. Malech, and S. K. Ahuja. 1998. Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-γ and IL-12. J. Immunol. 161:868.
32. Borriello, F., J. Lederer, S. Scott, and A. H. Sharpe. 1997. MRC OX-2 defines a novel T cell costimulatory pathway. J. Immunol. 158:4548.
33. Gorczynski, R. M., M. S. Cattral, Z. Chen, J. Hu, J. Lei, W. P. Min, G. Yu, and J. Ni. 1999. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J. Immunol. 163: 1654.
34. + tumor cells. Cancer Immunol. Immunother. 47:143.
35. Arai, H., D. Gordon, E. G. Nabel, and G. J. Nabel. 1997. Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA 94:13862.
36. Okamoto, K., H. Asahara, T. Kobayashi, H. Matsuno, T. Hasunuma, T. Kobata, T. Sumida, and K. Nishioka. 1998. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther. 5:331.
37. Stassi, G., M. Todaro, F. Bucchieri, A. Stoppacciaro, F. Farina, G. Zummo, R. Testi, and R. De Maria. 1999. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J. Immunol. 162:263.
38. Saito, I., K. Haruta, M. Shimuta, H. Inoue, H. Sakurai, K. Yamada, N. Ishimaru, H. Higashiyama, T. Sumida, H. Ishida, et al. 1999. Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J. Immunol. 162:2488.
39. Li, X. K., T. Okuyama, A. Tamura, S. Enosawa, Y. Kaneda, S. Takahara, N. Funashima, M. Yamada, H. Amemiya, and S. Suzuki. 1998. Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid. Transplantation 66:1416.
40. Gainer, A. L., W. L. Suarez-Pinzon, W. P. Min, J. R. Swiston, C. Hancock-Friesen, G. S. Korbutt, R. V. Rajotte, G. L. Warnock, and J. F. Elliott. 1998. Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-1g or soluble Fas ligand. Transplantation 66:194.
41. Lau, H. T., M. Yu, A. Fontana, and C. J. Stoeckert, Jr. 1996. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109.
42. Rosen, H., and S. Gordon. 1990. The role of the type-3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse. Am. J. Respir. Cell Mol. Biol. 3:3.
43. Kupiec-Weglinski, J. W., J. M. Austyn, and P. J. Morris. 1988. Migration patterns of dendritic cells in the mouse: traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues J. Exp. Med. 167:632.
44. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
45. Hammerling, G. J., G. Schonrich, F. Momburg, N. Auphan, M. Malissen, A. M. Schmitt-Verhulst, and B. Arnold. 1991. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of foreign MHC class I antigen. Immunol. Rev. 122:47.
46. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2 effectors undergo rapid Fas/FasL-mediated apoptosis. J. Immunol. 185:1837.
47. Matsue, H., K. Matsue, M. Walters, K. Okumura, H. Yagita, and A. Takashima. 1999. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected "killer" dendritic cells. Nat. Med. 5:930.
48. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
49. Muruve, D. A., A. G. Nicolson, R. C. Manfro, T. B. Strom, V. P. Sukhatme, and T. A. Libermann. 1997. Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts. Hum. Gene Ther. 8:955.
50. Kang, S.-M., D. Schneider, Z. Lin, D. Hanahan, D. Dichek, P. Stock, and S. Baekkeskov. 1997. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:738.
51. Chen, J.-J., Y. Sun, and G. Nabel. 1998. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282:1714.
52. + T cells. J. Immunol. 162: 5287.
53. Josien, R., B. Wong, H. Li, R. Steinman, and Y. Choi. 1999. TRANCE, a TNF family member, is differentially expressed on T cell subset and induces cytokine production in dendritic cells. J. Immunol. 162:2562.
54. 33+ dendritic cell precursors from multipotent progenitors is regulated by a discrete Fas-mediated apoptotic schedule. J. Leukocyte Biol. 62:493.
55. Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H. L. Li, R. M. Steinman, and Y. Choi. 1997, TRANCE (tumor necrosis factor (TNF)-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186:2075.
56. Bjorck, P., J. Banchereau, and L. Flores-Romo. 1997. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int. Immunol. 9:365.
57. Ludewig, B., D. Graf, H. R. Gelderblom, Y. Becker, R. A. Kroczek, and G. Pauli. 1995. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25:1943.
58. Nishimura, Y., A. Ishii, Y. Kobayashi, Y. Yamasaki, and S. Yonehara. 1995. Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol. 154:4395.
59. Suda, T., H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata. 1997, Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp. Med. 186:2045.
60. + cells. Gene Ther. 5:465.
61. Reeves, M. E., R. E. Royal, J. S. Lam, S. A. Rosenberg, and P. Hwu. 1996. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56:5672.
62. Di Nicola, M. S. Siena, M. Bregni, P. Longoni, M. Magni, M. Milanesi, P. Matteucci, R. Mortarini, A. Anichini, G. Parmiani, et al. 1998. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors. Cancer Gene Ther. 5:350.
63. Van Tendeloo, V. F., H. W. Snoeck, F. Lardon, G. L. Vanham, G. Nijs, M. Lenjou, L. Hendriks, C. Van Broeckhoven, A. Moulijn, I. Rodrigus, et al. 1998. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor-but not monocyte-derived dendritic cells. Gene Ther. 5:700.
64. + T cells after eene gun immunization. J. Exp. Med. 188:1075.